This is a delivery order awarded by the Veterans Integrated Service Network 20 of the Department of Veterans Affairs to Grifols Therapeutics LLC, a for-profit limited liability company that manufactures and supplies pharmaceuticals. The contract is for the delivery of the drug Prolastin and has a ceiling value of $83,755.20. The contract is a Firm Fixed Price delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not have a...
This is a federal contract award for PROLASTIN, a pharmaceutical product, issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule 61-IB. The contract is a delivery order with a firm fixed price of $75,000.00 and a period of...
This is a Firm Fixed Price delivery order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC. The award is for the bulk supply of Prolastin, a pharmaceutical drug, for the period from February 1, 2016 to January 31, 2017, with a potential ceiling value of $320,438.40. The award does not utilize any set-aside designation. Grifols Therapeutics LLC is a...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $223,184.16, is for the provision of PROLASTIN C, a pharmaceutical product, to the VA under the Pharmaceuticals and Drugs GSA Schedule contract. The contract is a firm fixed-price delivery order with a period of performance ending on September 30, 2017. The contract was...
This is a delivery order issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The $278,987.52 firm fixed price award is for the provision of unspecified DRUG products under the Pharmaceuticals and Drugs GSA Schedule contract. The order has a period of performance ending on March 15, 2017 and does not utilize a small business set-aside....
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...
This is a delivery order contract awarded by the Department of Veterans Affairs to Grifols Therapeutics LLC for the supply of Prolastin, a pharmaceutical product. The contract has a ceiling value of $144,000.00 and a period of performance from October 1, 2015 to September 30, 2016. It is a firm fixed price contract issued under the Pharmaceuticals and Drugs GSA Schedule. The award does not utilize any small business set-asides. Grifols Therapeutics LLC is a for-profit manufacturer and supplier...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of PROLASTIN-C, a pharmaceutical product, with a ceiling value of $214,014.72 and a period of performance through September 30, 2016. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule vehicle and does not utilize...
This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,612.48, was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and involves the procurement of various pharmaceutical products such as Prolastin, Prolastin-C, and immune globulin. The contract has an ultimate completion date of May 25, 2017 and does...